Search for: "Boehringer Ingelheim, Inc."
Results 81 - 100
of 155
Sort by Relevance
|
Sort by Date
29 Dec 2011, 6:53 am
PLIVA, Inc. v. [read post]
9 Aug 2011, 4:30 am
Boehringer Ingelheim Pharma., Inc., C.A. [read post]
5 Aug 2011, 6:21 am
Boehringer Ingelheim Pharmaceuticals, Inc., Pfizer, Inc., Pharmacia Corporation and Pharmacia & Upjohn, LLC, Nabil Gazal sued the maker of Mirapex for breach of warranty and failure to warn after he developed a serious gambling problem he ascribed to treatment with Mirapex. [read post]
28 Jul 2011, 11:19 am
Boehringer Ingelheim Pharmaceuticals, No. 10-3129, slip op. (8th Cir. [read post]
24 Jul 2011, 1:21 pm
Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
12 Jul 2011, 6:59 am
The trouble started when Lilly entered a different agreement this year with Amylin competitor Boehringer Ingelheim to sell a rival diabetes drug: BI’s Tradjenta. [read post]
9 Jun 2011, 12:43 pm
But Lilly recently struck a deal to promote a rival diabetes drug, Tradjenta, with Germany’s Boehringer Ingelheim using the same sales force. [read post]
4 May 2011, 10:00 am
Tradjenta is marketed by Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Conn., and Indianapolis-based Eli Lilly Co. [read post]
9 Feb 2011, 2:51 pm
Litig., MDL No. 2211 In re Student-Athlete Name & Likeness Litig., MDL No. 2212 In re Crystal Poole IRS Summons Litig., MDL No. 2216 In re Boehringer Ingelheim Pharm., Inc., Fair Labor Standards Act (FLSA) Litig., MDL No. 2219 Blawgletter wonders whether the fact that the Panel rejected motions to centralize cases in fully half of the MDL matters -- nine out of 18 -- made for quicker decisions. [read post]
31 Jan 2011, 8:10 am
Terminal Disclaimers and Section 121 Boehringer Ingelheim International GmbH v. [read post]
31 Jan 2011, 8:10 am
Terminal Disclaimers and Section 121 Boehringer Ingelheim International GmbH v. [read post]
19 Dec 2010, 9:44 am
--Naik v Boehringer Ingelheim Pharm, Inc., 7thCir, November 22, 2010, No. 09-2960: Summary judgment upheld for employer after 53-year-old former pharmaceutical sales rep failed to show that termination based on falsification of call records, was pretext for age and national origin (Indian) discrimination in violation of the Age Discrimination in Employment Act (ADEA) and Title VII.The employer's legitimate non-discriminatory reason (LNDR) was pretty damning against… [read post]
17 Dec 2010, 11:05 am
Boehringer Ingelheim Pharmaceuticals, Inc., slip op. (8th Cir. [read post]
9 Dec 2010, 3:53 am
" Specifically, "Boehringer Ingelheim GmbH's Roxane Inc. will pay $280 million, Abbott will pay $126.5 million and B. [read post]
9 Dec 2010, 2:49 am
” Specifically, “Boehringer Ingelheim GmbH’s Roxane Inc. will pay $280 million, Abbott will pay $126.5 million and B. [read post]
7 Dec 2010, 2:43 am
As for Roxane: Roxane is paying $280 million to resolve claims against it and related entities (Roxane Laboratories Inc., Boehringer Ingelheim Corp. and Boehringer Ingelheim Pharmaceuticals Inc.). [read post]
22 Nov 2010, 11:14 am
Employment National origin discrimination Where an employee falsified his call records, summary judgment was properly granted to the employer on the claim that he was terminated because of his national origin. [read post]
2 Nov 2010, 1:40 am
Genentech, Inc. v. [read post]
27 Oct 2010, 9:30 am
Pradaxa, manufactured by Boehringer Ingelheim Pharmaceuticals Inc. of Ridgefield, Conn., will be available in 75 milligram and 150 milligram capsules. [read post]
25 Oct 2010, 9:55 pm
Sandoz Inc. v. [read post]
